Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Nov 15 2025

Nov 14, 2025 at 10:40 PM EST · Issued by Alembic Pharmaceuticals Limited via NSE India

Filed with NSE · Nov 14, 2025 at 10:40 PM EST · 2 pages · English

On 6ix: 6ix.com/news/alembic-pharmaceuticals-limited-press-release-nov-15-2025

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 15, 2025, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Press Release Nov 13 2025Nov 13, 2025
Press Release Nov 07 2025Nov 7, 2025
Press Release (Revised) Nov 04 2025Nov 4, 2025
Press Release Nov 04 2025Nov 4, 2025
Press Release Oct 29 2025Oct 29, 2025

Later from Alembic Pharmaceuticals

Press Release Dec 11 2025Dec 11, 2025
Press Release Dec 18 2025Dec 18, 2025
Press Release Jan 12 2026Jan 12
Press Release Jan 27 2026Jan 27
Press Release Feb 05 2026Feb 5

All Alembic Pharmaceuticals news releases

Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.

Follow Alembic Pharmaceuticals